Cargando…
Identifying metabolic alterations in newly diagnosed small cell lung cancer patients
BACKGROUND: Small cell lung cancer (SCLC) is a malignant disease with poor prognosis. At the time of diagnosis most patients are already in a metastatic stage. Current diagnosis is based on imaging, histopathology, and immunohistochemistry, but no blood-based biomarkers have yet proven to be clinica...
Autores principales: | Pedersen, Shona, Hansen, Joachim Bavnhøj, Maltesen, Raluca Georgiana, Szejniuk, Weronika Maria, Andreassen, Trygve, Falkmer, Ursula, Kristensen, Søren Risom |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8455369/ https://www.ncbi.nlm.nih.gov/pubmed/34585134 http://dx.doi.org/10.1016/j.metop.2021.100127 |
Ejemplares similares
-
Characterising Alzheimer's disease through integrative NMR- and LC-MS-based metabolomics
por: Nielsen, Jonas Ellegaard, et al.
Publicado: (2021) -
Circulating microvesicles and exosomes in small cell lung cancer by quantitative proteomics
por: Pedersen, Shona, et al.
Publicado: (2022) -
Increased activity of procoagulant factors in patients with small cell lung cancer
por: Pedersen, Shona, et al.
Publicado: (2021) -
Metabotyping Patients’ Journeys Reveals Early Predisposition to Lung Injury after Cardiac Surgery
por: Maltesen, Raluca Georgiana, et al.
Publicado: (2017) -
Shotgun-based proteomics of extracellular vesicles in Alzheimer’s disease reveals biomarkers involved in immunological and coagulation pathways
por: Nielsen, Jonas Ellegaard, et al.
Publicado: (2021)